characteristics.text: SAMD00436376
characteristics.characteristic: External Id
characteristics.text: Melsmon Pharmaceuticals
characteristics.characteristic: INSDC center name
characteristics.text: 2022-05-18T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-06-02T10:46:17.367Z
characteristics.characteristic: INSDC last update
characteristics.text: DRS240291
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: DRS240291
characteristics.characteristic: SRA accession
characteristics.text: 66
characteristics.characteristic: age
characteristics.text: 2
characteristics.characteristic: biological replicate
characteristics.text: Cell Applications
characteristics.characteristic: biomaterial provider
characteristics.text: Normal human dermal fibroblast
characteristics.characteristic: cell type
characteristics.text: NHDF cells Melsmon treated (3x24hr treatment with 500ug/ml melsmon) biological replicate 2
characteristics.characteristic: description
characteristics.text: Caucasian female
characteristics.characteristic: isolation source
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: 8
characteristics.characteristic: passage_history
characteristics.text: NHDF melsmon rep 2
characteristics.characteristic: sample name
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: NHDF melsmon rep 2
characteristics.characteristic: title
characteristics.text: Melsmon
characteristics.characteristic: treatment